262 related articles for article (PubMed ID: 30778669)
1. Doxorubicin treatments induce significant changes on the cardiac autonomic nervous system in childhood acute lymphoblastic leukemia long-term survivors.
Caru M; Corbin D; Périé D; Lemay V; Delfrate J; Drouin S; Bertout L; Krajinovic M; Laverdière C; Andelfinger G; Sinnett D; Curnier D
Clin Res Cardiol; 2019 Sep; 108(9):1000-1008. PubMed ID: 30778669
[TBL] [Abstract][Full Text] [Related]
2. Cardiac autonomic dysfunction in survivors of acute lymphoblastic leukemia in childhood.
Kamath MV; Halton J; Harvey A; Turner-Gomes S; McArthur A; Barr RD
Int J Oncol; 1998 Mar; 12(3):635-40. PubMed ID: 9472104
[TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine changes during the evolution of doxorubicin-induced left ventricular dysfunction in adult lymphoma patients.
Nousiainen T; Vanninen E; Jantunen E; Remes J; Ritanen E; Vuolteenaho O; Hartikainen J
Clin Sci (Lond); 2001 Dec; 101(6):601-7. PubMed ID: 11724646
[TBL] [Abstract][Full Text] [Related]
4. Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial.
Lipshultz SE; Scully RE; Lipsitz SR; Sallan SE; Silverman LB; Miller TL; Barry EV; Asselin BL; Athale U; Clavell LA; Larsen E; Moghrabi A; Samson Y; Michon B; Schorin MA; Cohen HJ; Neuberg DS; Orav EJ; Colan SD
Lancet Oncol; 2010 Oct; 11(10):950-61. PubMed ID: 20850381
[TBL] [Abstract][Full Text] [Related]
5. Effect of long-term music therapy intervention on autonomic function in anthracycline-treated breast cancer patients.
Chuang CY; Han WR; Li PC; Song MY; Young ST
Integr Cancer Ther; 2011 Dec; 10(4):312-6. PubMed ID: 21382955
[TBL] [Abstract][Full Text] [Related]
6. Impaired mitochondrial function is abrogated by dexrazoxane in doxorubicin-treated childhood acute lymphoblastic leukemia survivors.
Lipshultz SE; Anderson LM; Miller TL; Gerschenson M; Stevenson KE; Neuberg DS; Franco VI; LiButti DE; Silverman LB; Vrooman LM; Sallan SE;
Cancer; 2016 Mar; 122(6):946-53. PubMed ID: 26762648
[TBL] [Abstract][Full Text] [Related]
7. Cardiac autonomic modulation induced by doxorubicin in a rodent model of colorectal cancer and the influence of fullerenol pretreatment.
Potočnik N; Perše M; Cerar A; Injac R; Finderle Ž
PLoS One; 2017; 12(7):e0181632. PubMed ID: 28727839
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of ABCC5 and NOS3 genes influence doxorubicin cardiotoxicity in survivors of childhood acute lymphoblastic leukemia.
Krajinovic M; Elbared J; Drouin S; Bertout L; Rezgui A; Ansari M; Raboisson MJ; Lipshultz SE; Silverman LB; Sallan SE; Neuberg DS; Kutok JL; Laverdière C; Sinnett D; Andelfinger G
Pharmacogenomics J; 2016 Nov; 16(6):530-535. PubMed ID: 26345518
[TBL] [Abstract][Full Text] [Related]
9. Cardiac autonomic dysfunction in patients with gastroesophageal reflux disease.
Milovanovic B; Filipovic B; Mutavdzin S; Zdravkovic M; Gligorijevic T; Paunovic J; Arsic M
World J Gastroenterol; 2015 Jun; 21(22):6982-9. PubMed ID: 26078576
[TBL] [Abstract][Full Text] [Related]
10. Dexrazoxane Treatments Limits Subclinical Cardiac Dysfunction in Childhood Acute Lymphoblastic Leukemia Survivors Exposed to Doxorubicin Treatments.
Lapointe MO; Caru M; Curnier D; Raboisson MJ; Andelfinger G; Krajinovic M; Laverdière C; Sinnett D; Périé D
J Pediatr Hematol Oncol; 2023 Mar; 45(2):70-77. PubMed ID: 36161876
[TBL] [Abstract][Full Text] [Related]
11. Cardioprotection and Safety of Dexrazoxane in Patients Treated for Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Advanced-Stage Lymphoblastic Non-Hodgkin Lymphoma: A Report of the Children's Oncology Group Randomized Trial Pediatric Oncology Group 9404.
Asselin BL; Devidas M; Chen L; Franco VI; Pullen J; Borowitz MJ; Hutchison RE; Ravindranath Y; Armenian SH; Camitta BM; Lipshultz SE
J Clin Oncol; 2016 Mar; 34(8):854-62. PubMed ID: 26700126
[TBL] [Abstract][Full Text] [Related]
12. Protective role of black seed oil in doxorubicin-induced cardiac toxicity in children with acute lymphoblastic leukemia.
Hagag AA; Badraia IM; El-Shehaby WA; Mabrouk MM
J Oncol Pharm Pract; 2020 Sep; 26(6):1397-1406. PubMed ID: 31964219
[TBL] [Abstract][Full Text] [Related]
13. Modelling cardiac mechanics in doxorubicin-induced cardiotoxicity following childhood acute lymphoblastic leukemia using a combination of cardiac magnetic resonance imaging, cardiopulmonary exercise testing and the CircAdapt model.
Artz T; Caru M; Curnier D; Abasq M; Krajinovic M; Laverdière C; Sinnett D; Périé D
J Biomech; 2023 Jun; 154():111616. PubMed ID: 37207545
[TBL] [Abstract][Full Text] [Related]
14. Cardioprotection against the toxic effects of anthracyclines given to children with cancer: a systematic review.
Bryant J; Picot J; Levitt G; Sullivan I; Baxter L; Clegg A
Health Technol Assess; 2007 Jul; 11(27):iii, ix-x, 1-84. PubMed ID: 17610809
[TBL] [Abstract][Full Text] [Related]
15. Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia.
Lipshultz SE; Lipsitz SR; Sallan SE; Dalton VM; Mone SM; Gelber RD; Colan SD
J Clin Oncol; 2005 Apr; 23(12):2629-36. PubMed ID: 15837978
[TBL] [Abstract][Full Text] [Related]
16. Anthracycline's Effects on Heart Rate Variability in Children with Acute Lymphoblastic Leukemia: Early Toxicity Signs-Pilot Study.
Lazar DR; Cainap S; Maniu D; Blag C; Bota M; Lazar FL; Achim A; Colceriu MC; Zdrenghea M
J Clin Med; 2023 Nov; 12(22):. PubMed ID: 38002666
[TBL] [Abstract][Full Text] [Related]
17. Assessment of heart rate variability in hypertrophic cardiomyopathy. Association with clinical and prognostic features.
Counihan PJ; Fei L; Bashir Y; Farrell TG; Haywood GA; McKenna WJ
Circulation; 1993 Oct; 88(4 Pt 1):1682-90. PubMed ID: 8403313
[TBL] [Abstract][Full Text] [Related]
18. Possible Ameliorative Effect of Ivabradine on the Autonomic and Left Ventricular Dysfunction Induced by Doxorubicin in Male Rats.
El-Naggar AE; El-Gowilly SM; Sharabi FM
J Cardiovasc Pharmacol; 2018 Jul; 72(1):22-31. PubMed ID: 29688913
[TBL] [Abstract][Full Text] [Related]
19. Circadian heart rate variability in patients with primary arterial hypertension.
Kolasińska-Kloch W; Furgała A; Banach T; Laskiewicz J; Thor PJ
Przegl Lek; 2002; 59(9):752-5. PubMed ID: 12632903
[TBL] [Abstract][Full Text] [Related]
20. The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia.
Lipshultz SE; Rifai N; Dalton VM; Levy DE; Silverman LB; Lipsitz SR; Colan SD; Asselin BL; Barr RD; Clavell LA; Hurwitz CA; Moghrabi A; Samson Y; Schorin MA; Gelber RD; Sallan SE
N Engl J Med; 2004 Jul; 351(2):145-53. PubMed ID: 15247354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
